Correlation Between Milestone Pharmaceuticals and Ideaya Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Ideaya Biosciences, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Ideaya Biosciences.

Diversification Opportunities for Milestone Pharmaceuticals and Ideaya Biosciences

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Milestone and Ideaya is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Ideaya Biosciences go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and Ideaya Biosciences

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Ideaya Biosciences. In addition to that, Milestone Pharmaceuticals is 1.51 times more volatile than Ideaya Biosciences. It trades about -0.01 of its total potential returns per unit of risk. Ideaya Biosciences is currently generating about 0.04 per unit of volatility. If you would invest  2,187  in Ideaya Biosciences on August 26, 2024 and sell it today you would earn a total of  492.00  from holding Ideaya Biosciences or generate 22.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Milestone Pharmaceuticals  vs.  Ideaya Biosciences

 Performance 
       Timeline  
Milestone Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Ideaya Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ideaya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Milestone Pharmaceuticals and Ideaya Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Milestone Pharmaceuticals and Ideaya Biosciences

The main advantage of trading using opposite Milestone Pharmaceuticals and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.
The idea behind Milestone Pharmaceuticals and Ideaya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data